Cited by 103HIV Research and TreatmentRNA Research and SplicingHIV/AIDS drug development and treatment

HIV-1 RNA packaging

Lever, Andrew M.L.·2007·Advances in Pharmacology

Integrity signals

Registry

Crossref · 10.1016/s1054-3589(07)55001-5

Cites

187 of 187 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Retroviral genome packaging takes place with great specificity despite the RNA being present in low abundance in infected cells compared to host and viral subgenomic RNAs.

    “This takes place with great specificity despite being present in low abundance in the infected cells in comparison to host and viral subgenomic RNAs”
  • Structured motifs in RNA packaging elements often include stem-loops, bulges, and unpaired purine-rich sequences that serve as high-affinity Gag binding sites.

    “These structured motifs often include stem-loops, bulges, and unpaired purine-rich sequences that serve as high-affinity Gag binding sites”
  • RNA packaging elements form complex secondary and tertiary structures across diverse retroviruses, including HIV-1, MMTV, MPMV, and FIV.

    “Structure–function studies across diverse retroviruses, including HIV-1, MMTV, MPMV, and FIV, have consistently demonstrated that RNA packaging elements form complex secondary and tertiary structures.”

Cites

Flagged first, then by citations

1 of the 188 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Lever, A. M. L.
Affiliations
University of Cambridge (GB)
Corresponding author
Lever, Andrew M.L.
Venue
Advances in Pharmacology
Publisher
Elsevier
Published
2007
Volume
55
Pages
1-32
ISSN
1054-3589 (ISSN-L)
OpenAlex
W1540217756
Cited by
103
References
188
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 11 · 2017: 3 · 2016: 5 · 2015: 7 · 2014: 4 · 2013: 7 · 2012: 8
FWCI
8.71
Type
book chapter
Language
en
Open access
closed
Locations
  • Advances in pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
HIV-1, RNA packaging, RNA encapsidation, Gag protein, retroviral RNA, RNA-RNA interactions, RNA transport, molecular chaperones, RNA conformational change, cis-regulatory elements, RNA export, antiviral drug targets
MeSH terms
Amino Acid Sequence, Animals, Base Sequence, Capsid, Humans, Molecular Sequence Data, Nucleic Acid Conformation, RNA, Viral, Viral Proteins, HIV-1, Virus Assembly

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review